{
  "state": "illinois",
  "path": "title-chapter-410-public-health/chapter-410-ilcs-240-newborn-metabolic-screening-act",
  "sections": [
    {
      "id": "section-001",
      "number": "0.01.",
      "heading": "Short title. This Act may be cited as the",
      "text": "Newborn Metabolic Screening\nAct.",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-1",
      "number": "1.",
      "heading": "The Illinois Department of Public Health shall promulgate and",
      "text": "enforce rules and regulations requiring that every newborn be subjected\nto tests for genetic, metabolic, and congenital anomalies as the\nDepartment may deem necessary. The Department is\nempowered to promulgate such additional rules and regulations as are\nfound necessary for the administration of this Act, including mandatory\nreporting of the results of all tests for these conditions to the\nIllinois Department of Public Health.",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-15",
      "number": "1.5.",
      "heading": "Definitions. In this Act:",
      "text": "Definitions. In this Act:",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-110",
      "number": "1.10.",
      "heading": "Critical congenital heart disease.",
      "text": "Critical congenital heart disease.",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-2",
      "number": "2.",
      "heading": "General provisions. The Department of Public Health shall administer the",
      "text": "provisions of this Act and shall:",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-3",
      "number": "3.",
      "heading": "The provisions of this Act shall not apply when parent or",
      "text": "guardian of the child objects thereto on the grounds that such test\nconflicts with his religious tenets and practices. A written statement\nof such objection shall be presented to the physician or other person\nwhose duty it is to administer and report such tests under the\nprovisions of this Act.",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-31",
      "number": "3.1.",
      "heading": "Lysosomal storage disorders. In accordance with the timetable specified in this Section, the Department shall provide all newborns with screening tests for the presence of certain lysosomal storage disorders known as Krabbe, Pompe, Gaucher, Fabry, and Niemann-Pick",
      "text": "The testing shall begin within 6 m",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-32",
      "number": "3.2.",
      "heading": "Severe combined immunodeficiency disease",
      "text": "In accordance with the timetable specified in this Section, the Department shall provide all newborns with screening tests for the presence of severe combined immunodeficiency\ndisease (SCID). The testing shall begin within 12 months following the occurrence of all of the following:",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-33",
      "number": "3.3.",
      "heading": "Mucopolysacchardosis disorders",
      "text": "In accordance with the timetable specified in this Section, the Department shall provide all newborns with screening tests for the presence of certain lysosomal storage disorders\nknown as mucopolysaccharidosis I (Hurlers) and mucopolysaccharidosis II (Hunters). The testing shall begin within 12 months following the occurrence of all of the following:",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-34",
      "number": "3.4.",
      "heading": "Adrenoleukodystrophy. In accordance with the timetable specified in this Section, the Department shall provide all newborns with screening tests for the presence of adrenoleukodystrophy (ALD)",
      "text": "The testing shall begin within 18 months following the occurrence of all of the following:",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-35",
      "number": "3.5.",
      "heading": "Metachromatic leukodystrophy.",
      "text": "Metachromatic leukodystrophy.",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-36",
      "number": "3.6.",
      "heading": "Duchenne muscular dystrophy.",
      "text": "Duchenne muscular dystrophy.",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-335",
      "number": "3.35.",
      "heading": "Spinal muscular atrophy. In accordance with the timetable specified in this Section, the Department shall provide all newborns with a screening test for spinal muscular atrophy using a method that determines the presence or absence of the intact or normal SMN1 gene, beginning on the earlier of the f",
      "text": "Spinal muscular atrophy. In accordance with the timetable specified in this Section, the Department shall provide all newborns with a screening test for spinal muscular atrophy using a method that determines the presence or absence of the intact or normal SMN1 gene, beginning on the earlier of the following:",
      "history": "",
      "source_url": ""
    }
  ]
}